PUBLIC HEALTH RESEARCH GROUP
•
0 likes•1 view
This document summarizes information about a public health research group at Universidad Cardenal Herrera-CEU in Spain. The group focuses on "one health" approaches to controlling communicable diseases, new diagnostic and treatment technologies, and has expertise in areas like drug screening, cell cultures, immunological assays, and PCR. The group has fully equipped laboratories and collaborates internationally with universities in Bolivia, Paraguay, Argentina, and the UK on projects related to disease prevention, treatment, and behavior change interventions.
Report
Share
Report
Share
Download to read offline
Recommended
THERAPEUTIC STRATEGIES IN OCULAR DISEASES GROUP
The Therapeutic Strategies in Ocular Diseases Group at the Universidad Cardenal Herrera-CEU in Valencia, Spain studies degenerative eye diseases like retinitis pigmentosa and diabetic retinopathy. Led by María Miranda Sanz, the 9 member group has extensive experience developing and testing potential new drug therapies in animal models. They collaborate internationally and have modern facilities for research including an experimental lab, HPLC, immunohistochemistry, and electroretinography. The group aims to find neuroprotective substances that prolong the life of cells in the visual system and help define the molecular mechanisms of various eye conditions.
Poison information centre
The number of chemicals, poisonous household products and medicines on the Indian market it is increasing day by day which can frequently increases the risk of misuse of these products and leads to Greater incidence of intentional and unintentional poisoning.
poisoninformationcentre about drugs -.pdf
The document discusses the organization and resources of poison information centres (PICs). It describes that PICs provide toxicological information and advice for poisoning cases. They also conduct research, education and laboratory analysis. PICs first emerged in Europe in the 1940s in response to increasing poisoning incidents. In India, the first national PIC was established in 1994. Effective PICs require multidisciplinary teams, 24/7 availability, libraries of poison resources and facilities for toxicology analysis and communication.
chapter 1
The document discusses the history, structure, and role of medical laboratories. It begins by defining a medical laboratory and tracing the history from informal training in the 1940s-50s to modern degree programs. It describes the structure of laboratory services from community health centers up to national reference laboratories. Finally, it outlines the important role of laboratories in providing quality healthcare through accurate diagnosis, screening, and epidemiological surveillance. Medical laboratory personnel play a vital role in diagnosing disease, monitoring treatment, and ensuring optimal patient care. Laboratories also adhere to strict rules of ethics, conduct, and policies to ensure quality testing.
Medical Laboratory Sciences
In the era of modern technology, health care delivery system involves so many different personnel and specialties that the caregiver must have an understanding and working knowledge of other professional endeavors, including the role of diagnostic evaluation.
Basically, laboratory and diagnostic tests are tools by and of themselves, they are not therapeutic.
In conjunction with a pertinent history and physical examination, these tests can confirm a diagnosis or provide valuable information about a patient status and response to therapy.
In addition to these, laboratory findings are essential for epidemiological surveillance and research purposes.
If the entire network of a laboratory service is to be effectively utilized and contribute to health care and disease prevention, every member of its work force need to:
Understand the role of the laboratory and its contribution to the nation’s health service;
Appreciate the need to involve all members in the provision of health service;
Follow professional ethics and code of conduct;
Experience job satisfaction and have professional loyalty.
Medical laboratory science is a complex field embracing a number of different disciplines such as
Microbiology,
Hematology,
Clinical Chemistry,
Urinalysis,
Immunology,
Serology,
Histopathology,
Immunohematology and
Molecular biology and others
Orphanetics Presentation
Orphanetics aims to create new biotechnology companies focused on rare and ultra-rare diseases by evaluating therapeutic opportunities, conducting de-risking experiments, and seeking candidates compatible with forming new ventures; it utilizes a collaborative model working with various organizations to identify assets, de-risk programs, and accelerate the formation of new companies developing therapeutics for diseases with unmet medical needs.
Orphanetics presentation
Orphanetics aims to create new biotechnology companies focused on rare and ultra-rare diseases by evaluating therapeutic opportunities, conducting de-risking experiments through collaborations, and establishing new venture-backed companies upon demonstrating proof of concept in man for priority rare disease projects.
basic information resource.pptx
This document discusses information resources in pharmacovigilance. It defines pharmacovigilance as relating to detecting, assessing, understanding, and preventing adverse drug reactions. It outlines the objectives to understand drug information sources and select appropriate ones. It describes primary, secondary, and tertiary resources, providing examples and advantages and disadvantages of each. It also discusses establishing pharmacovigilance programs and centers, including basic steps, operational requirements, and planning considerations.
Recommended
THERAPEUTIC STRATEGIES IN OCULAR DISEASES GROUP
The Therapeutic Strategies in Ocular Diseases Group at the Universidad Cardenal Herrera-CEU in Valencia, Spain studies degenerative eye diseases like retinitis pigmentosa and diabetic retinopathy. Led by María Miranda Sanz, the 9 member group has extensive experience developing and testing potential new drug therapies in animal models. They collaborate internationally and have modern facilities for research including an experimental lab, HPLC, immunohistochemistry, and electroretinography. The group aims to find neuroprotective substances that prolong the life of cells in the visual system and help define the molecular mechanisms of various eye conditions.
Poison information centre
The number of chemicals, poisonous household products and medicines on the Indian market it is increasing day by day which can frequently increases the risk of misuse of these products and leads to Greater incidence of intentional and unintentional poisoning.
poisoninformationcentre about drugs -.pdf
The document discusses the organization and resources of poison information centres (PICs). It describes that PICs provide toxicological information and advice for poisoning cases. They also conduct research, education and laboratory analysis. PICs first emerged in Europe in the 1940s in response to increasing poisoning incidents. In India, the first national PIC was established in 1994. Effective PICs require multidisciplinary teams, 24/7 availability, libraries of poison resources and facilities for toxicology analysis and communication.
chapter 1
The document discusses the history, structure, and role of medical laboratories. It begins by defining a medical laboratory and tracing the history from informal training in the 1940s-50s to modern degree programs. It describes the structure of laboratory services from community health centers up to national reference laboratories. Finally, it outlines the important role of laboratories in providing quality healthcare through accurate diagnosis, screening, and epidemiological surveillance. Medical laboratory personnel play a vital role in diagnosing disease, monitoring treatment, and ensuring optimal patient care. Laboratories also adhere to strict rules of ethics, conduct, and policies to ensure quality testing.
Medical Laboratory Sciences
In the era of modern technology, health care delivery system involves so many different personnel and specialties that the caregiver must have an understanding and working knowledge of other professional endeavors, including the role of diagnostic evaluation.
Basically, laboratory and diagnostic tests are tools by and of themselves, they are not therapeutic.
In conjunction with a pertinent history and physical examination, these tests can confirm a diagnosis or provide valuable information about a patient status and response to therapy.
In addition to these, laboratory findings are essential for epidemiological surveillance and research purposes.
If the entire network of a laboratory service is to be effectively utilized and contribute to health care and disease prevention, every member of its work force need to:
Understand the role of the laboratory and its contribution to the nation’s health service;
Appreciate the need to involve all members in the provision of health service;
Follow professional ethics and code of conduct;
Experience job satisfaction and have professional loyalty.
Medical laboratory science is a complex field embracing a number of different disciplines such as
Microbiology,
Hematology,
Clinical Chemistry,
Urinalysis,
Immunology,
Serology,
Histopathology,
Immunohematology and
Molecular biology and others
Orphanetics Presentation
Orphanetics aims to create new biotechnology companies focused on rare and ultra-rare diseases by evaluating therapeutic opportunities, conducting de-risking experiments, and seeking candidates compatible with forming new ventures; it utilizes a collaborative model working with various organizations to identify assets, de-risk programs, and accelerate the formation of new companies developing therapeutics for diseases with unmet medical needs.
Orphanetics presentation
Orphanetics aims to create new biotechnology companies focused on rare and ultra-rare diseases by evaluating therapeutic opportunities, conducting de-risking experiments through collaborations, and establishing new venture-backed companies upon demonstrating proof of concept in man for priority rare disease projects.
basic information resource.pptx
This document discusses information resources in pharmacovigilance. It defines pharmacovigilance as relating to detecting, assessing, understanding, and preventing adverse drug reactions. It outlines the objectives to understand drug information sources and select appropriate ones. It describes primary, secondary, and tertiary resources, providing examples and advantages and disadvantages of each. It also discusses establishing pharmacovigilance programs and centers, including basic steps, operational requirements, and planning considerations.
WHAT IS CLINICAL LABORATORY SCIENCE
Clinical laboratory science, also known as medical laboratory science or medical technology, is the health profession that provides laboratory services and information needed to diagnose and treat disease. Clinical laboratory scientists perform laboratory tests to detect conditions like cancer, infections, and genetic disorders. They ensure accurate test results and work to evaluate new testing methods. Molecular diagnostic science is a specialized area of clinical laboratory science that uses sensitive techniques like DNA analysis to identify biomarkers and aid in medical diagnosis, prognosis, disease monitoring, and treatment selection.
Epidemiology of periodontal diseases
This document provides an overview of epidemiology and periodontal disease. It defines epidemiology and describes its aims, principles, approaches, tools of measurement, and study designs. Descriptive epidemiology is discussed, including defining a population, disease, and describing disease distribution. Analytical epidemiology studies like case-control and cohort studies are also summarized. Key points covered include the epidemiologic triad of agent, host, and environment, and prevalence and incidence rates.
A review on stages of drug development and alternative methods for animal stu...
Various Stages of drug development, anaesthesia ,euthanasia, animals used for preclinical analysis, clinical trials, alternative methods for animal testing, blood withdrawal methods, ethical guidelines
The future of the pharmaceutical industry
The document discusses the future of the pharmaceutical industry through examining three levels - the inner level of pharmaceutical science/R&D, middle level of business environment, and outer level of healthcare context. For the inner level, it outlines advances in areas like stem cells, medical devices, and personalized medicine. The middle level may see new business models through increased cooperation. For the outer level, it notes how patients are becoming more informed and active in decision making. The document concludes that while the future is difficult to predict, the industry must balance its missions with maintaining public trust.
JPND Research Strategy presentation T. Gasser
The document outlines the JPND Research Strategy, which was developed through workshops and consultations with academics, industry, funders, policymakers, healthcare professionals, patients, and carers. The strategy focuses on three domains - scientific, medical, and social. It identifies priorities for research into neurodegenerative disease origins and mechanisms, improved diagnosis, prevention and treatment development, and optimized healthcare systems. The strategy also describes enabling activities needed to support collaboration and translate research into policy and practice.
RESEARCH GROUP NOVEL DRUG DELIVERY SYSTEMS
The multidisciplinary research group works on developing controlled drug delivery systems through various routes of administration to improve patients' quality of life. Their areas of expertise include ocular and transdermal drug delivery, absorption enhancement, iontophoresis, and prediction of skin and ocular penetration and bioavailability. They have 18 years of experience in multidisciplinary drug delivery research and focus on developing drugs, therapeutic systems, and medical devices for long-term diseases. Their research interests include transdermal and ocular delivery systems allowing modified drug release, as well as innovative 3D printed systems using new active substances and biomaterials.
Lecture 10 : Animal Diseases
This document provides information about disease investigation techniques, materials needed for laboratory investigation, and the establishment of animal health centers. It discusses techniques for investigating disease outbreaks and epidemics, as well as the objectives and phases of disease surveillance. It also outlines the different types of samples that can be collected from animals for laboratory analysis, and the proper procedures and materials needed for sample collection. Finally, it describes the goals, services, and assistance provided by animal health centers, which work to diagnose and prevent the spread of diseases among livestock populations.
Scope of pharmacology
This document provides an overview of the scope of pharmacology. It discusses the history and evolution of pharmacology from materia medica and early pharmacy to its modern academic, industrial and research applications. Key areas of pharmacology discussed include drug development process, clinical pharmacology, special domains like pharmacovigilance, pharmacoeconomics and emerging areas like pharmacogenomics. The document outlines the past, present and future scope of pharmacology and how it aims to advance human health through rational and safe use of medicines.
Medical Laboratory sciences
Medical laboratory scientists work in hospital laboratories performing tests on blood, urine, and other bodily fluids to help diagnose and treat diseases. They arrive early to have test results ready for doctors' morning patient visits. Their responsibilities include confirming abnormal results, performing quality control, conducting analytical tests on fluids and substances, and maintaining laboratory equipment. Medical laboratories contain various instruments and reagents to examine samples from departments like hematology, blood banking, microbiology, chemistry, serology, and pathology. Medical laboratory services play an important role in health systems by aiding diagnosis and treatment, monitoring infectious diseases, and informing public health measures.
Clinical trials dhruva
Clinical trials are conducted in phases to evaluate the safety and efficacy of new medical interventions in humans. Phase I trials involve small groups of subjects and focus on safety, tolerability and dosing of new drugs. Phase II trials involve larger groups of patients and aim to establish effectiveness and optimal dosing. Phase III trials involve thousands of subjects and compare the new medical intervention to the current standard of care or placebo under blinded conditions. The results of phase III trials are required for regulatory approval prior to widespread use and administration of the new medical intervention.
Drud Discovery - Dr. Amsavel.pdf
Drug Discovery path
Pharma R & D –overview
Discovery & Development
Preclinical research
Clinical Trial
NDA and FDA Approval
Post marketing data
References
Clinical Research Regulation
Clinical Research Regulation:
Various types of Clinical Study, Phases of Clinical Trial, Clinical Trial Protocol..
Drug discovery and development together are the complete process of identifying a new drug and bringing it to market.
Discovery may involve
Screening of chemical libraries
Identification of the active ingredient from a natural remedy.
Design resulting from an understanding of the target.
Development includes 0
Studies on microorganisms and animals.
Analytical method development and validation
Clinical trials and ultimately regulatory approval.
Drug Development/Approval Process..
Types of Clinical Study: Descriptive and Analytical..
Difference between Case Control and Cohort Study
Phases of Clinical Study
Phase 0: Phase 0 includes exploratory, first-in-human (FIH) trials that are carried out in accordance with FDA regulations.
The single subtherapeutic doses are administered to 10 to 15 volunteers in phase 0 trials, which are also known as human micro dose studies. These trials provide pharmacokinetic data or aid in the imaging of certain targets without causing pharmacological effects.
Phase 1: The initial evaluation of a medicine is done in phase I studies, which use fewer healthy human participants.
Phase 1 typically involves 20 to 80 healthy volunteers who have the illness or condition. Patients are often only utilized when a drug's mechanism of action indicates that healthy individuals will not tolerate it.
Nonetheless, researchers carry out Phase 1 studies in patients with that particular form of diabetes if a new medication is recommended for use in diabetic patients.
Phase 2: The purpose of phase II studies, which involve larger patient populations (a few hundreds), is to confirm the results of phase I safety evaluations and examine the drug's efficacy.
These tests are insufficient to determine whether the medicine will be effective in treating patients.
Phase 3: Researchers plan Phase 3 studies to prove whether a product deals an action benefit to a specific people or not.
Sometimes known as pivotal studies/ pilot, these studies comprise 300 to 3,000 volunteers.
Phase 3 studies deliver most of the safety data.
Phase 4: Phase 4 trials are conducted when the drug or device has been approved by FDA.
These trials are also recognized as post-marketing surveillance involving pharmacovigilance and continuing technical support after approval.
There are numerous observational strategies and assessment patterns used in Phase 4 trials to evaluate the efficacy, cost-effectiveness, and safety of an involvement in real-world settings.
Task Force on One-Health Approach to Influenza publishes summary of its findi...
A task force of 18 influenza experts published a summary of their findings on a one-health approach to influenza in the CDC's Emerging Infectious Diseases journal. The task force recommends improving vaccines and production capacity, expanding surveillance of influenza viruses in humans, livestock, pets and wildlife, improving early detection in humans and animals, developing tools to interrupt transmission, and applying developments in molecular biology. The full report is available on the FAZD Center's website.
Covid- 19 Vaccines
This document provides information about COVID-19 vaccines, including their development process and types. It discusses the phases of clinical drug trials, with Phase 1 trials testing safety in a small group and Phase 3 trials comparing the new vaccine to the standard treatment in thousands of participants. The document also outlines regulatory bodies involved in vaccine development and describes two main types - mRNA vaccines, which introduce mRNA coding for the antigen, and viral vector vaccines, which use another virus to produce the spike protein antigen.
Introduction to drug discovery and development.pptx
The document provides an overview of drug discovery and development. It discusses the various stages including discovery, preclinical research, clinical trials (phases 1-4), regulatory approval, and post-approval surveillance. The discovery stage involves identifying drug targets and lead compounds. Preclinical research involves safety testing in animals. Clinical trials test safety and efficacy in humans in phases. Regulatory agencies approve drugs that are proven safe and effective. Post-approval surveillance monitors drugs after market release. The overall process aims to develop innovative therapies while ensuring patient safety.
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical is a clinical research organization headquartered in Dundee, Scotland that manages clinical trials from Phase I-IV. It has locations also in Latvia and provides services to pharmaceutical and medical device companies of all sizes. Onorach focuses on innovative electronic solutions to improve clinical trial quality and efficiency. It has expertise across many therapeutic areas including oncology, diabetes, vaccines, and more. Onorach aims to deliver high-quality, cost-effective clinical trial services through strategic partnerships.
Housing companies in a research center: the CIPF experience
The document summarizes the CIPF experience housing biotech companies at their research center. It discusses (1) their motivation was to offer companies the same resources they provide researchers, including lab space, equipment, and access to technological expertise and collaborative research groups, (2) their approach is a collaboration agreement where companies pay monthly fees for the scientific and technological infrastructure services they utilize, and (3) their goals are to help early-stage spin-offs partner with larger companies and facilitate technology transfer from the research center to the market.
Drug Information.
Drug information involves providing clinically relevant information about drug use to patients or healthcare professionals. A drug information center specializes in answering questions about medicines and provides unbiased information to support rational drug use and patient care. When answering drug information queries, pharmacists follow a systematic process of understanding the request, researching resources, evaluating evidence, formulating a response, and documenting outcomes.
PATHOLOGY AND ANIMAL HEALTH GROUP
The group consists of 8 veterinary researchers who study Staphylococcus aureus infections. Their work includes studying the genetic factors of S. aureus and its effects on rabbit immune responses. They collaborate with companies on vaccine and phagotherapy methods to treat S. aureus infections. The group also provides pathology diagnostic services and studies various animal diseases. They have well-equipped research facilities and interests in antibiotic-resistant S. aureus strains and developing therapeutic tools for staphylococcal treatment in veterinary and human medicine.
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
This slide is useful to the life science student. It include the detailed information of toxicology and guidelines for conducting toxicity study.
Wound healing PPT
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxMohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
More Related Content
Similar to PUBLIC HEALTH RESEARCH GROUP
WHAT IS CLINICAL LABORATORY SCIENCE
Clinical laboratory science, also known as medical laboratory science or medical technology, is the health profession that provides laboratory services and information needed to diagnose and treat disease. Clinical laboratory scientists perform laboratory tests to detect conditions like cancer, infections, and genetic disorders. They ensure accurate test results and work to evaluate new testing methods. Molecular diagnostic science is a specialized area of clinical laboratory science that uses sensitive techniques like DNA analysis to identify biomarkers and aid in medical diagnosis, prognosis, disease monitoring, and treatment selection.
Epidemiology of periodontal diseases
This document provides an overview of epidemiology and periodontal disease. It defines epidemiology and describes its aims, principles, approaches, tools of measurement, and study designs. Descriptive epidemiology is discussed, including defining a population, disease, and describing disease distribution. Analytical epidemiology studies like case-control and cohort studies are also summarized. Key points covered include the epidemiologic triad of agent, host, and environment, and prevalence and incidence rates.
A review on stages of drug development and alternative methods for animal stu...
Various Stages of drug development, anaesthesia ,euthanasia, animals used for preclinical analysis, clinical trials, alternative methods for animal testing, blood withdrawal methods, ethical guidelines
The future of the pharmaceutical industry
The document discusses the future of the pharmaceutical industry through examining three levels - the inner level of pharmaceutical science/R&D, middle level of business environment, and outer level of healthcare context. For the inner level, it outlines advances in areas like stem cells, medical devices, and personalized medicine. The middle level may see new business models through increased cooperation. For the outer level, it notes how patients are becoming more informed and active in decision making. The document concludes that while the future is difficult to predict, the industry must balance its missions with maintaining public trust.
JPND Research Strategy presentation T. Gasser
The document outlines the JPND Research Strategy, which was developed through workshops and consultations with academics, industry, funders, policymakers, healthcare professionals, patients, and carers. The strategy focuses on three domains - scientific, medical, and social. It identifies priorities for research into neurodegenerative disease origins and mechanisms, improved diagnosis, prevention and treatment development, and optimized healthcare systems. The strategy also describes enabling activities needed to support collaboration and translate research into policy and practice.
RESEARCH GROUP NOVEL DRUG DELIVERY SYSTEMS
The multidisciplinary research group works on developing controlled drug delivery systems through various routes of administration to improve patients' quality of life. Their areas of expertise include ocular and transdermal drug delivery, absorption enhancement, iontophoresis, and prediction of skin and ocular penetration and bioavailability. They have 18 years of experience in multidisciplinary drug delivery research and focus on developing drugs, therapeutic systems, and medical devices for long-term diseases. Their research interests include transdermal and ocular delivery systems allowing modified drug release, as well as innovative 3D printed systems using new active substances and biomaterials.
Lecture 10 : Animal Diseases
This document provides information about disease investigation techniques, materials needed for laboratory investigation, and the establishment of animal health centers. It discusses techniques for investigating disease outbreaks and epidemics, as well as the objectives and phases of disease surveillance. It also outlines the different types of samples that can be collected from animals for laboratory analysis, and the proper procedures and materials needed for sample collection. Finally, it describes the goals, services, and assistance provided by animal health centers, which work to diagnose and prevent the spread of diseases among livestock populations.
Scope of pharmacology
This document provides an overview of the scope of pharmacology. It discusses the history and evolution of pharmacology from materia medica and early pharmacy to its modern academic, industrial and research applications. Key areas of pharmacology discussed include drug development process, clinical pharmacology, special domains like pharmacovigilance, pharmacoeconomics and emerging areas like pharmacogenomics. The document outlines the past, present and future scope of pharmacology and how it aims to advance human health through rational and safe use of medicines.
Medical Laboratory sciences
Medical laboratory scientists work in hospital laboratories performing tests on blood, urine, and other bodily fluids to help diagnose and treat diseases. They arrive early to have test results ready for doctors' morning patient visits. Their responsibilities include confirming abnormal results, performing quality control, conducting analytical tests on fluids and substances, and maintaining laboratory equipment. Medical laboratories contain various instruments and reagents to examine samples from departments like hematology, blood banking, microbiology, chemistry, serology, and pathology. Medical laboratory services play an important role in health systems by aiding diagnosis and treatment, monitoring infectious diseases, and informing public health measures.
Clinical trials dhruva
Clinical trials are conducted in phases to evaluate the safety and efficacy of new medical interventions in humans. Phase I trials involve small groups of subjects and focus on safety, tolerability and dosing of new drugs. Phase II trials involve larger groups of patients and aim to establish effectiveness and optimal dosing. Phase III trials involve thousands of subjects and compare the new medical intervention to the current standard of care or placebo under blinded conditions. The results of phase III trials are required for regulatory approval prior to widespread use and administration of the new medical intervention.
Drud Discovery - Dr. Amsavel.pdf
Drug Discovery path
Pharma R & D –overview
Discovery & Development
Preclinical research
Clinical Trial
NDA and FDA Approval
Post marketing data
References
Clinical Research Regulation
Clinical Research Regulation:
Various types of Clinical Study, Phases of Clinical Trial, Clinical Trial Protocol..
Drug discovery and development together are the complete process of identifying a new drug and bringing it to market.
Discovery may involve
Screening of chemical libraries
Identification of the active ingredient from a natural remedy.
Design resulting from an understanding of the target.
Development includes 0
Studies on microorganisms and animals.
Analytical method development and validation
Clinical trials and ultimately regulatory approval.
Drug Development/Approval Process..
Types of Clinical Study: Descriptive and Analytical..
Difference between Case Control and Cohort Study
Phases of Clinical Study
Phase 0: Phase 0 includes exploratory, first-in-human (FIH) trials that are carried out in accordance with FDA regulations.
The single subtherapeutic doses are administered to 10 to 15 volunteers in phase 0 trials, which are also known as human micro dose studies. These trials provide pharmacokinetic data or aid in the imaging of certain targets without causing pharmacological effects.
Phase 1: The initial evaluation of a medicine is done in phase I studies, which use fewer healthy human participants.
Phase 1 typically involves 20 to 80 healthy volunteers who have the illness or condition. Patients are often only utilized when a drug's mechanism of action indicates that healthy individuals will not tolerate it.
Nonetheless, researchers carry out Phase 1 studies in patients with that particular form of diabetes if a new medication is recommended for use in diabetic patients.
Phase 2: The purpose of phase II studies, which involve larger patient populations (a few hundreds), is to confirm the results of phase I safety evaluations and examine the drug's efficacy.
These tests are insufficient to determine whether the medicine will be effective in treating patients.
Phase 3: Researchers plan Phase 3 studies to prove whether a product deals an action benefit to a specific people or not.
Sometimes known as pivotal studies/ pilot, these studies comprise 300 to 3,000 volunteers.
Phase 3 studies deliver most of the safety data.
Phase 4: Phase 4 trials are conducted when the drug or device has been approved by FDA.
These trials are also recognized as post-marketing surveillance involving pharmacovigilance and continuing technical support after approval.
There are numerous observational strategies and assessment patterns used in Phase 4 trials to evaluate the efficacy, cost-effectiveness, and safety of an involvement in real-world settings.
Task Force on One-Health Approach to Influenza publishes summary of its findi...
A task force of 18 influenza experts published a summary of their findings on a one-health approach to influenza in the CDC's Emerging Infectious Diseases journal. The task force recommends improving vaccines and production capacity, expanding surveillance of influenza viruses in humans, livestock, pets and wildlife, improving early detection in humans and animals, developing tools to interrupt transmission, and applying developments in molecular biology. The full report is available on the FAZD Center's website.
Covid- 19 Vaccines
This document provides information about COVID-19 vaccines, including their development process and types. It discusses the phases of clinical drug trials, with Phase 1 trials testing safety in a small group and Phase 3 trials comparing the new vaccine to the standard treatment in thousands of participants. The document also outlines regulatory bodies involved in vaccine development and describes two main types - mRNA vaccines, which introduce mRNA coding for the antigen, and viral vector vaccines, which use another virus to produce the spike protein antigen.
Introduction to drug discovery and development.pptx
The document provides an overview of drug discovery and development. It discusses the various stages including discovery, preclinical research, clinical trials (phases 1-4), regulatory approval, and post-approval surveillance. The discovery stage involves identifying drug targets and lead compounds. Preclinical research involves safety testing in animals. Clinical trials test safety and efficacy in humans in phases. Regulatory agencies approve drugs that are proven safe and effective. Post-approval surveillance monitors drugs after market release. The overall process aims to develop innovative therapies while ensuring patient safety.
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical is a clinical research organization headquartered in Dundee, Scotland that manages clinical trials from Phase I-IV. It has locations also in Latvia and provides services to pharmaceutical and medical device companies of all sizes. Onorach focuses on innovative electronic solutions to improve clinical trial quality and efficiency. It has expertise across many therapeutic areas including oncology, diabetes, vaccines, and more. Onorach aims to deliver high-quality, cost-effective clinical trial services through strategic partnerships.
Housing companies in a research center: the CIPF experience
The document summarizes the CIPF experience housing biotech companies at their research center. It discusses (1) their motivation was to offer companies the same resources they provide researchers, including lab space, equipment, and access to technological expertise and collaborative research groups, (2) their approach is a collaboration agreement where companies pay monthly fees for the scientific and technological infrastructure services they utilize, and (3) their goals are to help early-stage spin-offs partner with larger companies and facilitate technology transfer from the research center to the market.
Drug Information.
Drug information involves providing clinically relevant information about drug use to patients or healthcare professionals. A drug information center specializes in answering questions about medicines and provides unbiased information to support rational drug use and patient care. When answering drug information queries, pharmacists follow a systematic process of understanding the request, researching resources, evaluating evidence, formulating a response, and documenting outcomes.
PATHOLOGY AND ANIMAL HEALTH GROUP
The group consists of 8 veterinary researchers who study Staphylococcus aureus infections. Their work includes studying the genetic factors of S. aureus and its effects on rabbit immune responses. They collaborate with companies on vaccine and phagotherapy methods to treat S. aureus infections. The group also provides pathology diagnostic services and studies various animal diseases. They have well-equipped research facilities and interests in antibiotic-resistant S. aureus strains and developing therapeutic tools for staphylococcal treatment in veterinary and human medicine.
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
This slide is useful to the life science student. It include the detailed information of toxicology and guidelines for conducting toxicity study.
Similar to PUBLIC HEALTH RESEARCH GROUP (20)
A review on stages of drug development and alternative methods for animal stu...
A review on stages of drug development and alternative methods for animal stu...
Task Force on One-Health Approach to Influenza publishes summary of its findi...
Task Force on One-Health Approach to Influenza publishes summary of its findi...
Introduction to drug discovery and development.pptx
Introduction to drug discovery and development.pptx
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Onorach Clinical; Onorach Baltics; Onorach Innovation ceating disruptive serv...
Housing companies in a research center: the CIPF experience
Housing companies in a research center: the CIPF experience
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Recently uploaded
Wound healing PPT
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxMohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)Academy of Science of South Africa
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Librarians are leading the way in creating future-ready citizens – now we need to update our spaces to match. In this session, attendees will get inspiration for transforming their library spaces. You’ll learn how to survey students and patrons, create a focus group, and use design thinking to brainstorm ideas for your space. We’ll discuss budget friendly ways to change your space as well as how to find funding. No matter where you’re at, you’ll find ideas for reimagining your space in this session.
Main Java[All of the Base Concepts}.docx
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...Nguyen Thanh Tu Collection
https://app.box.com/s/qhtvq32h4ybf9t49ku85x0n3xl4jhr15How to Fix the Import Error in the Odoo 17
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Physical pharmaceutics notes for B.pharm students
clinical examination of hip joint (1).pdf
described clinical examination all orthopeadic conditions .
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
How to deliver Powerpoint Presentations.pptx
"How to make and deliver dynamic presentations by making it more interactive to captivate your audience attention"
Hindi varnamala | hindi alphabet PPT.pdf
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
PCOS corelations and management through Ayurveda.
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
How to Setup Warehouse & Location in Odoo 17 Inventory
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
Recently uploaded (20)
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
Reimagining Your Library Space: How to Increase the Vibes in Your Library No ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
BÀI TẬP DẠY THÊM TIẾNG ANH LỚP 7 CẢ NĂM FRIENDS PLUS SÁCH CHÂN TRỜI SÁNG TẠO ...
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
How to Setup Warehouse & Location in Odoo 17 Inventory
How to Setup Warehouse & Location in Odoo 17 Inventory
PUBLIC HEALTH RESEARCH GROUP
- 1. CONTACT M. AUXILIADORA DEA-AYUELA mdea@uchceu.es OUR GROUP 1. OURWORK The research group focuses on three areas: • “One health” is a concept recently created, which seeks to join efforts between doctors, pharmacists, veterinarians and other health personnel together with the administrations for the control of communicable diseases, especially zoonotic, such as giardiosis, hy- datidosis or leishmaniasis. • New technologies in diagnostic and thera- py in the control of various communicable diseases. 4. FACILITIES • Fully equipped research laboratories, sample processing laboratory; flow cyto- meter; co-observation microscope room, fluorescence detection Instruments, PCR thermal cycler, etc… 2. RESEARCH INTERESTS 3. EXPERTISE AND EXPERIENCE Wide experience and valuable knowledge in: • Drug screening in different parasites and mi- croorganisms. • Cell cultures to assess drug toxicity. • Proteomics tools. • Immunological assays (western-blot, ELISA, cytokine measurement). • PCR. • Nutritional status evaluation. • International projects. • Collaboration and exchange of international researchers between groups, both in short stays and for the shared direction of doctoral theses. POSSIBILITIES FOR COLLABORATION5. OUR GROUP A multidisciplinary team of pharmacists, biologists, nutritionists and physicians experts in health. Castellón Team UCH-CEU Valencia Team UCH-CEU OUR INTERNATIONAL COLLABORATORS UMSA (Bolivia) CEDIC (Paraguay) UNP (Argentina) University of Portsmouth (UK) OUR NATIONAL COLLABORATORS • Participation in projects related to the development of prevention and thera- peutic tools for the control of zoonotic pathogens. • Participation in projects related to de- signing and implementing change in behavior interventions to improve po- pulation health. PUBLIC HEALTH RESEARCH GROUP HEALTH SCIENCES FACULTY UNIVERSIDAD CARDENAL HERRERA-CEU, CEU UNIVERSITIES - MONCADA, VALENCIA, SPAIN